Understanding the Genetic Architecture of Parkinson's Disease
The Global Parkinson’s Genetics Program (GP2) is an ambitious five-year program to genotype >150,000 volunteers around the world to further understand the genetic architecture of Parkinson’s disease (PD). There is still much to learn about genetic risk factors and the path to further understanding requires working collaboratively and openly sharing data, processes, and results.
Submit a Cohort
Collaborate with us and submit a cohort to GP2. Fill out our form to get started.
Check out the latest news about GP2.
Development is an important component of our program; our focus is to provide training and other funding opportunities for the next generation of Parkinson’s disease researchers around the world. GP2 will offer these opportunities to the entire neurodegeneration community through the course of the program.
Latest Blog Posts
Read the latest blogs from GP2’s scientists and collaborators.
Open Science Opens Doors
In GP2, underlying data, analytical processes, and results will be made available to the research community as quickly as possible, with minimal barriers to access and use. The latest blog post by Bradford Casey highlights the value and importance of open science.
A letter to the patient community from Randy Schekman, ASAP Scientific Director
ASAP Scientific Director, Randy Schekman, expresses his personal and professional connection with Parkinson's disease in a letter to the patient community, shared by patient advocate Benjamin Stecher.
Find out about GP2’s working groups and their recently accomplished milestones.